The risk of developing diabetes after suffering from COVID-19
Tell us how we can help.
Bring BASE10’s kits to your pharmacy.
Your Health Starts Here
Thank you for sending us a message!
For immediate concerns, you may reach our customer and sales support at +1 (866) 710 1018 or email us at sales@base10genetics.com +1 (866) 710 1018 sales@base10genetics.com info@base10genetics.com +1 (866) 710 1018 Patient Portal Pharmacists Login LTC Administrators/Providers More on Clinical Decision Algorithms Medical/Healthcare Facilities Corporate Pharmacies More on Genomics Corporate Pharmacy Long-Term Care Facilities About Us PlexusDX Resources News and Articles Careers Events Medical/Healthcare Facilities Corporate Pharmacies More on Clinical Decision Algorithms Corporate Pharmacy Long-Term Care Facilities More on Genomics About Us PlexusDX Resources News and Articles Careers Events Contact Us Contact Us A new study has found that people who suffer even mild cases of COVID-19 have a 40% chance of developing diabetes within a year of recovering, and that likelihood grows if the patient suffered a serious infection that led to hospitalization or time in the ICU. Senior author Soumya Raychaudhuri, MD, Ph.D., said, “The risk of developing diabetes is not just related to how severe the disease is. It’s also related to the amount of time someone has been exposed to the virus.” This latest finding adds to an already growing list of research indicating that people who have had COVID-19 are at risk for long-term health problems like heart disease and kidney disease. A study published in late March in the Lancet Diabetes & Endocrinology journal gives insight into the potential long-term effects of COVID-19, and it’s not what we expected. Although COVID-19 is primarily a respiratory illness, researchers have found that 1-2% of people who’ve had COVID will develop diabetes. The study analyzed data from over 180,000 patients from the U.S. Department of Veterans Affairs and compared patients who tested positive for COVID-19 and survived it with over 4 million other people who didn’t contract COVID in the same time period. Although this percentage may seem small, it translates to 800,000 to 1.6 million people who are now at risk of getting diabetes—a condition they may not have developed without having had COVID-19. Researchers believe this study and continued research will hopefully create awareness among physicians and nurses to screen patients who’ve had COVID for diabetes and other long-term health complications so they can be treated appropriately. Learn about how to effectively track and monitor infections in your facility, using a customizable automated solution > Learn about how to effectively track and monitor infections in your facility, using a customizable automated solution >
About BASE10 Genetics, Inc.
Located in Chicago, BASE10 is a healthcare software technology company whose platform creates turnkey disease management programs that can be deployed at scale for nursing home operators, pharmacies, payors, and self-funded employers.
Tags
more on clinical decision algorithms medical/healthcare facilities corporate pharmacies more on genomics corporate pharmacy long-term care facilities about us plexusdx resources news and articles careers events medical/healthcare facilities corporate pharmacies more on clinical decision algorithms corporate pharmacy long-term care facilities more on genomics about us plexusdx resources news and articles careers events contact us contact us
Other articles you might like
PlexusDX got COLA Accreditation
PlexusDX got COLA Accreditation
Dr. Irene Hamrick’s Health Updates
COVID-19 Vaccination Update The CDC has issued a COVID vaccination guide at a glance. It … Why Precision is the Future of Medicine
Get Plugged-In: Listen to this exclusive Persimmon Digital Health Community podcast with B…
Why Precision is the Future of Medicine
Get Plugged-In: Listen to this exclusive Persimmon Digital Health Community podcast with B…